Trial of Gene Therapy for Sickle Cell Disease Halted
TUESDAY, Feb. 23, 2021 -- A clinical trial of a new gene therapy for sickle cell disease that has shown promise has been halted after two participants were diagnosed with cancer.
Therapy developer Bluebird Bio said a patient who was treated five...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Gene Therapy | Genetics | Pharmaceuticals | Sickle Cell Anemia